MedTrace Logo

Piloting a Naloxone Intervention in Philadelphia

NCT03305497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2021-09-22

No results posted yet for this study

Summary

The escalating opioid overdose epidemic is one of the most serious public health problems confronting the U.S. Death due to drug overdose is a significant and rising cause of mortality and morbidity in Philadelphia. While naloxone is increasingly accessible to combat opioid overdoses, new responses to delivering naloxone to overdose events are needed. The proposed pilot project, to be conducted in Philadelphia, will pursue three specific aims: 1) Identify barriers and facilitators of acceptance and use of a smartphone-based naloxone intervention; 2) Pilot test the implementation of the intervention among 55 non-medical opioid users and 55 community members; 3) Synthesize knowledge acquired in Aims 1 and 2 to be used in a subsequent R01 study to conduct a large-scale, multi-site implementation trial.

Conditions

  • Opioids; Harmful Use

Interventions

BEHAVIORAL

Mobile Phone Application

110 persons will be equipped with a mobile phone application, trained in overdose prevention, and equipped with naloxone. The mobile phone app will allow persons witnessing an overdose to signal persons in the vicinity to respond with naloxone.

Sponsors & Collaborators

  • Bar-Ilan University, Israel

    collaborator OTHER

  • Drexel University

    lead OTHER

Principal Investigators

  • Stephen Lankenau, PhD · Drexel University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-23
Primary Completion
2020-05-31
Completion
2021-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03305497 on ClinicalTrials.gov